A recent study of b-hemolytic Escherichia coli isolated from diarrheic swine found that 53% were resistant to chloramphenicol, a drug that has been prohibited from use in food animals in the US since the mid-1980s. To identify the factors governing the persistence of chloramphenicol resistance in the absence of specific selection pressure, the location of the chloramphenicol resistance gene cmlA and its linkage to other resistance determinants were investigated. Southern blot analysis of plasmid DNA from 46 swine E. coli isolates indicated that cmlA was present on large plasmids greater than 100 kbp. Fifty-two percent of the isolates were able to transfer chloramphenicol resistance to an E. coli recipient at conjugation frequencies ranging from 10 À3 to 10 À8 per recipient. Antimicrobial susceptibility tests on transconjugant strains demonstrated that resistance to sulfamethoxazole, tetracycline, and kanamycin frequently transferred along with chloramphenicol resistance. The transconjugant strains possessed at least two distinct class 1 integrons that linked cmlA to both aminoglycoside resistance genes aadA1 and aadA2 and either to sul1 or to sul3 sulphonamide resistance genes. These results suggest that in the absence of specific chloramphenicol selection pressure, the cmlA gene is maintained by virtue of gene linkage to genes encoding resistance to antimicrobials that are currently approved for use in food animals. Published by Elsevier B.V. on behalf of the Federation of European Microbiological Societies.
Introduction
Antimicrobials are valuable tools that animal producers use to quickly address clinical disease and to maintain healthy and productive animals [1] . Nevertheless, broad use of antimicrobials in agriculture can select for resistant bacteria that may enter the food chain and potentially result in food-borne illness in humans that is less responsive to treatment with conventional antibiotics [2] . In addition, antimicrobial resistant pathogens pose a severe and costly animal health problem, as they prolong illness and decrease productivity through higher morbidity and mortality rates.
A central element of mitigation efforts to combat the increasing rates of antimicrobial resistance is the reduction of selection pressures through limited availability and decreased usage of antimicrobial drugs. In general, this strategy has enjoyed some success, such as in Europe, where the prevalence of resistance to macrolide and to glycopeptide antibiotics decreased in enterococci isolated from farm animals following the ban on related antimicrobial growth promoters [3, 4] . However, there are reports of inconsistencies in the outcomes of this strategy. In recent Norwegian and Danish studies, vancomycin resistant enterococci persisted in broiler flocks after the ban of avoparcin for animal production, presumably because resistant strains survived extensive cleaning and disinfection of the broiler houses [5, 6] . In Denmark, studies of cases in which vancomycin resistance was linked to erythromycin resistance reported that the prevalence of resistance to either drug did not decrease until the use of avoparcin and tylosin, agents chemically related to vancomycin and erythromycin, respectively, was limited [3] . And in a human clinical setting, a British study reported that sulfonamide resistance in Escherichia coli persisted in the United Kingdom despite a national prescribing restriction, most likely because of genetic linkage of multiple resistance determinants [7] . Knowledge of the molecular factors that govern the persistence of resistance in enteric bacteria in the absence of obvious selection pressure is however limited. Thus, there is a need to further determine the genetic location and potential linkage of antimicrobial resistance determinants among multi-drug resistant bacterial pathogens.
E. coli is a common etiologic agent that causes diarrhea in young pigs [8] . In the United States, broad spectrum antimicrobials such as streptomycin, tetracycline, and sulfamethoxazole are used for treatment of bacterial enteritis in livestock. Prior to the mid-1980s, chloramphenicol was commonly prescribed for treatment of colibacillosis, but concerns over its toxicity in humans led the US Food and Drug Administration to prohibit its use in food animals [9, 10] . Nevertheless, a study on entertoxigenic E. coli isolated in 1998 from diarrheic pigs reported that 53% of the isolates exhibited resistance to chloramphenicol [11] . Serotyping and ribotyping data indicated that the high rate of chloramphenicol resistance in swine E. coli isolates did not represent the clonal expansion of a single resistant strain but rather the dissemination of the chloramphenicol resistance gene cmlA among genetically diverse E. coli isolates. The present study investigates chloramphenicol resistance in pathogenic swine E. coli isolates with respect to the genetic location and mobility of associated resistance determinants.
Materials and methods

Bacterial strains and growth media
The present study focuses on a chloramphenicolresistant subset (N = 46) of E. coli from a collection of b-hemolytic E. coli that were isolated from young diarrheic pigs and were described previously [11] . A nalidixic acid resistant strain of E. coli JM109, used as a recipient strain in conjugation experiments, was a gift from Dr. Shaohua Zhao, FDA Center for Veterinary Medicine, Laurel, MD. Tryptic soy broth (TSB) and tryptic soy agar (TSA) containing 5% sheep blood were purchased from Becton Dickenson, Sparks, MD. All cultures were grown at 37°C for 24 h.
Analysis of plasmids
Analysis of plasmid DNA from transconjugant strains used a Qiagen Plasmid Mini Kit to isolate plasmid according to the manufacturerÕs instructions. Approximately 200 ng of plasmid DNA was digested with six units of EcoRI restriction endonuclease in 15 ll of Multicore buffer (Promega Corporation, Madison, WI) for 1 h at 37°C. Samples were applied to a 1% agarose gel, and subjected to electrophoresis for 3 h at 40 V. Contents of the gel were transferred by capillary action to a nylon membrane, fixed by UV irradiation, and analyzed by Southern blot analysis [12] using a digoxigenin labeled probe generated by polymerase chain reaction using cmlA specific primers [13] . A DIG Labeling and Detection kit (Roche Diagnostics Corporation, Indianapolis, IN) was used to label the probe and to detect hybridized targets according to the manufacturerÕs instructions.
Transfer of chloramphenicol resistance genes
Mobility of the chloramphenicol resistance genes was determined by the filter mating method described by Clewell and others [14] . Transconjugants were selected on TSB agar plates containing chloramphenicol (16 lg ml À1 ) and nalidixic acid (16 lg ml À1 ). Transconjugant colonies were sub-cultured on blood agar plates containing the relevant antibiotics and characterized with respect to antimicrobial susceptibility phenotypes.
Polymerase chain reaction
Polymerase chain reaction was used to detect the presence of genes encoding chloramphenicol resistance (cmlA), class 1 integrase (intI1), and sulphonamide resistance (sul1, sul2, and sul3). DNA templates were prepared by the boil lysis method, and PCR was performed using oligonucleotide primer sets specific for these genes as described previously [13, 15, 16] . To determine the organizational structure of integrons containing cmlA, extra long PCR (GeneAmp XL PCR Kit, Applied Biosystems, Foster City, CA) was perfomed using the following primer sets: (1) intI1 forward and the cmlA reverse; (2) cmlA forward and sul1 reverse; and (3) cmlA forward and sul3 forward. Extra long PCR reactions (50 ll) contained: 1x XL Buffer II, 2.0 mM Mg(OAc) 2 , 0.8 mM dNTPs, 1 pmol ll À1 of each respective oligonucleotide primer, and three units rTth DNA polymerase. Reactions were subjected to 35 cycles of PCR with a denaturation temperature of 94°C (1 min), an annealing temperature of 45°C (0.5 min), and an extension temperature of 72°C (10 min). Amplicons were submitted for DNA sequencing at the DNA Core Facility in the Department of Veterinary Pathobiology, Texas A&M University, College Station, TX. Sequence comparisons were made using the BLAST program available at the National Center for Biotechnology Information [17] .
Determination of antimicrobial susceptibility
Antimicrobial susceptibility was determined by broth microdilution methods [18] using the Sensititre automated antimicrobial susceptibility system according to the manufacturerÕs instructions (Trek Diagnostic Systems, Westlake, OH). The following antimicrobials and resistance breakpoints (lg ml À1 ) were used: amikacin (AMI), 64; ampicillin (AMP), 32; apramycin (APR), 32; amoxicillin/clavulanic acid (AUG), 32/16; cephalothin (CEP), 32; chloramphenicol (CHL), 32; cefoxitin (FOX), 32; kanamycin (KAN), 64; nalidixic acid (NAL), 32; sulfamethoxazole (SMX), 512; streptomycin (STR), 64; tetracycline (TET), 16; ceftiofur (TIO), 8. Breakpoints were determined using NCCLS interpretive standards [18] unless unavailable, in which case breakpoints in the National Antimicrobial Resistance Monitoring System 2001 Annual Report [19] were used. E. coli ATCC 25922 and 35218, and Pseudomonas aeruginosa ATCC 27853 were used as quality control organisms in all antimicrobial susceptibility tests.
Results and discussion
Studies in the United States and in Europe have reported persistent rates of chloramphenicol resistance years after withdrawal of the drug from therapeutic use in animals [11, 20] . Since chloramphenicol is not approved for use in food animals in the United States, the high prevalence of the chloramphenicol resistance gene cmlA in swine E. coli is noteworthy [11] . Resistance to chloramphenicol may be mediated enzymatically through chloramphenicol acetyltransferase or non-enzymatically through the cmlA or flo genes, which both encode putative drug efflux pumps [21, 22] . The flo gene is similar in primary structure to cmlA and confers resistance to both florfenicol and chloramphenicol. It has previously been shown to be disseminated on large plasmids among genetically diverse strains of E. coli, and the use of florfenicol for treatment of respiratory infections in cattle may explain the selection of flo in bovine E. coli [23] . But neither chloramphenicol acetyltransferase nor cmlA confers resistance to florfenicol [24] . While it may be possible that florfenicol use may confer a low selection pressure for the cmlA gene, several studies in the literature suggest that persistence of resistance may be a result of the genetic linkage of resistance genes, where selection for one resistance marker selects for all markers [7, 25] . The aim of the present study was to determine whether the persistence of chloramphenicol resistance in swine E. coli might be explained by genetic linkage of cmlA to other resistance genes.
Localization of cmlA and mobility of chloramphenicol resistance
We have examined a chloramphenicol-resistant subset (N = 46) of b-hemolytic E. coli isolates that were isolated between 1998 and 1999 and that possessed the chloramphenicol resistance gene cmlA. To determine the presence and size of plasmids carrying cmlA from swine E. coli, we used a modification of the S1 nuclease/pulsed field gel electrophoresis (PFGE) method described by Barton et al. [26] . Southern blot analysis using a cmlA specific probe detected a single cmlA target in 45 of 46 isolates, indicating that cmlA was present on large (>100 kbp) plasmids (data not shown). The absence of signal from strain 1581 would be consistent with a chromosomal location of cmlA, as the PFGE method used here to determine the size of plasmids does not detect chromosomal DNA.
Twenty-four of forty-six isolates (52%) were able to transfer chloramphenicol resistance to an E. coli JM109 recipient strain with conjugation frequencies ranging from 10 À8 to 10 À3 per recipient (Table 1) . This suggests that conjugation of plasmids encoding cmlA is one mechanism for the wide dissemination of chloramphenicol resistance among swine E. coli. Interestingly, under the conditions employed in this study, all isolates belonging to the O149 and O139 serogroups transferred chloramphenicol resistance to the recipient E. coli strain, while none of those in the O147 serogroup did. Although there are few studies in the literature investigating the relationship between serogroup and plasmid conjugation, Danbara and co-workers reported a similar finding regarding serogroups of enterotoxigenic strains of E. coli isolated from human patients [27] . Strains from classical serogroups that were frequently associated with diarrhea were less likely to transfer enterotoxin plasmids to a recipient than strains from serogroups that were rarely associated with diarrhea [28] . Strains within these serogroups may differ in many characteristics, including the presence of other mobilizing plasmids and fimbrial types; thus further work on a larger sample size would need to be conducted before evaluating the significance of this observation.
PCR analysis of total DNA from transconjugant strains indicated that the cmlA gene was tranferred. None of the 24 donor strains possessed the chloramphenicol acetyltransferase gene cat or the florfenicol resistance gene flo, and therefore the presence of these genes in the transconjugant strains was not investigated. To confirm that resistance transfer occurred via conjugation of plasmids, plasmid DNA was isolated from the transconjugant strains, digested with the restriction enzyme EcoRI, and analyzed by Southern Blot using a cmlA specific probe. Comparison of restriction digest patterns between transconjugants strains indicated a genetically diverse set of plasmids (Fig. 1, upper panel) . The Southern blot analysis was less complex, however, with the cmlA probe hybridizing to a single target of 5 kbp (18 of 24 strains), 7.5 (4 of 24 strains), and >12 kbp (1 of 24 strains) (Fig. 1, lower panel) . In this analysis, EcoRI digestion of plasmid from transconjugant 1562 did not yield defined fragments; thus no cmlA target was detected by Southern blot. However, localization of cmlA to plasmid DNA from transconjugant 1562 was confirmed in a separate Southern blot analysis following digestion with the restriction enzyme NotI (data not shown). 
Antimicrobial susceptibility of transconjugant strains
Transconjugant strains derived from chloramphenicol resistant swine E. coli donors were tested for susceptibility to other antimicrobial agents. Co-transfer of resistance to at least one other antimicrobial was observed in all transconjugants ( Table 1 ). The predominant co-transferring resistances were to the following agents: sulfamethoxazole (24 of 24 transconjugants), tetracycline (21 of 24 transconjugants), and kanamycin (17 of 24 transconjugants). This is consistent with results from the initial study of chloramphenicol resistance in swine E. coli, which reported a statistically high level of significance for co-resistance to these same agents [11] . Since sulphonamides, aminoglycosides, and tetracycline are commonly used in swine in the United States, it supports the hypothesis that a genetic linkage between cmlA and resistance genes to these agents ensures persistence of the chloramphenicol resistance phenotype, even in the absence of a direct chloramphenicol selection pressure.
PCR analysis of DNA from transconjugant strains
Integrons are genetic structures consisting of two conserved segments that flank a central region where cassettes of resistance genes may accumulate. In general, class 1 integrons consist of antibiotic resistance gene cassettes flanked by the integrase gene intI1 and the sulfonamide resistance gene sul1 [29, 30] . The co-transfer of sulphonamide resistance in all 24 transconjugants suggested that cmlA may be part of an integron. PCR analysis of total genomic DNA confirmed the presence of the class 1 integrase gene intI1 in all transconjugant strains (data not shown). However, only four transconjugant strains (829, 839, 860, and 862) possessed sul1. Extension of the analysis to screen for related sulphonamide resistance genes sul2 and sul3, found that the remaining 20 transconjugant strains possessed sul3. The sul3 gene, which encodes a putative dihydropteroate synthase with 40% sequence identity to sul1, was first reported in 2003 [31] . Subsequent studies have documented its prevalence among E. coli from both animal and human sources in Europe, but it has not previously been reported in strains isolated in the United States [32, 33] .
Extra-long PCR using the intI1-forward and the cmlA-reverse primers detected specific amplicons in all 24 transconjugant strains (data not shown). Two distinct amplicons were detected: a 2.5 kbp amplicon in the four strains that possessed sul1, and a 4.0 kbp amplicon in the remaining strains. Analysis using the cmlA-forward primer and the sul1-reverse primer on transconjugant strains 829, 839, 860, and 862, yielded a 3.0 kbp amplicon. Similar analysis on the remaining 20 strains using cmlA-forward and sul3-reverse failed to produce an amplicon. Use of the cmlA-forward and the sul3-forward primers, however, gave a 5 kbp amplicon, indicating that the cmlA gene and sul3 gene are in opposite orientations.
As representatives of each distinct integron, the amplicons from transconjugant strains 862 and 1562 were sequenced. The organization of the two distinct integrons is shown in Fig. 2 . The structure of the integron from strain 862 is similar to that of P. aeruginosa plasmid R1033 transposon Tn1696 (GenBank Accession No. U12338), with cmlA in close proximity to the aminoglycoside resistance genes aadA2 and aadA1 and to sul1. The structure of the integron from strain 1562 is unique, as there are presently no sequences in the GenBank database that possess all of the following genes in order: the streptothricin resistance gene sat, the putative phosphoserine phosphatase gene psp, aadA2, cmlA, aadA1, the quaternary ammonium compound resistance gene qacH, and sul3. The 5 0 -end of the 1562 integron containing the sat, psp, and aadA2, is similar to one reported from a strain of E. coli O159 isolated in Japan [34] . The cmlA and aadA1 domain is similar that described for the P. aeruginosa plasmid R0133. The original characterization of sul3 on plasmid pVP440 reported that a truncated cmlA gene was localized downstream and in the same orientation of sul3 [31] . No other sequences in the database report the linkage of sul3 to other resistance gene cassettes or as part of an integron. Thus the data presented here not only describes a unique integron structure, but also demonstrates a direct genetic link between cmlA and genes encoding aminoglycoside and sulphonamide resistance. It is worth noting that while the transconjugant strains possessed aminoglycoside resistance genes, not all were resistant to streptomycin. The concentration of streptomycin in the antimicrobial susceptibility panels used in this study ranged from 32 to 256 lg ml À1 . All nine streptomycin resistant transconjugant strains had an MIC for streptomycin (resistance breakpoint = 64 lg ml À1 ) equal to 64 lg ml À1 , while the MIC in the susceptible strains could only be measured as 632 lg ml À1 . The streptomycin-susceptible phenotype in fifteen strains, despite possessing the aadA2 gene, may simply be a matter of what breakpoint is used, since there is no NCCLS approved interpretive criteria. Nevertheless, this data demonstrates a direct genetic link between cmlA and genes encoding aminoglycoside resistance enzymes.
Conclusion
This study illustrates the complexity of resistance dynamics, which must be taken into account when developing effective intervention strategies. Our results suggest that a mechanism for co-selection and maintenance of chloramphenicol resistance in pathogenic swine E. coli exists in the absence of direct selection pressure from phenicol use. Since co-resistance to sulfamethoxazole, tetracycline and kanamycin was observed among the majority of chloramphenicol resistant transconjugants, the use of any of these antimicrobials can result in the selection of bacteria resistant not only to that specific agent, but by genetic linkage of resistance genes, to other unrelated antimicrobial agents, in this case chloramphenicol. Therefore, the simultaneous reduction in the selection pressures of all co-selecting agents may be required to mitigate the dissemination of antimicrobial resistance in the animal production environment.
